Wednesday, July 8, 2026

Drug profile · INN

l-glutamine

l-glutamine (ENDARI) is a unknown. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 6
News articles 0
Drug details — l-glutamine
US status
approved
Class
Route
ORAL
Patents
1
Programs
6
Data quality
0.84

Quick answer

l-glutamine (ENDARI) is a unknown. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN l-glutamine
Brand ENDARI
Mechanism Unknown
Route ORAL
Formulation FOR SOLUTION

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. L-alanyl-L-glutamine dipeptide Phase 3 · Hospital Authority · Coronary Artery Bypass
  2. glutamine combined with thalidomide Phase 3 · Chinese Academy of · Mucositis Oral
  3. Glutamine Phase 2 · Chinese Academy of · Rheumatic Heart Disease
  4. L-Glutamine Phase 2 · BRIGHT MINDS BIOSCIENCES · Pulmonary Hypertension
  5. RESTORE Phase 2 · Istituto Gentili Italia · decompensated cirrhosis
  6. Glutamine Unknown · United Therapeutics Europe · Hemorrhagic Shock

Related patents

  1. US 9980931

    Use of glycyl glutamine against depression

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is l-glutamine?

l-glutamine (ENDARI) is a unknown. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for l-glutamine?

ENDARI is a marketed brand name for l-glutamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of l-glutamine?

l-glutamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.